Actavis And Valeant Announce FDA Approval For Metronidazole

Actavis and Valeant Pharmaceuticals announced in a press release that the Food and Drug Administration (FDA) has approved Metronidazole 1.3% Vaginal Gel. The approved New Drug Application (NDA) is for an antibiotic to treat bacterial vaginosis (BV).
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news